This was the question posed by Javier F. Magrina, MD, in his presidential address at the opening ceremony of the 42nd AAGL global congress on minimally invasive gynecology on November 11. His answer to this question (which of course referred to obstetrics and gynecology) was a resounding "yes," and he backed up this conviction with statistics and anecdotes that illustrated the need for specialized training in minimally invasive gynecologic procedures.
This was the question posed by Javier F. Magrina, MD, in his presidential address at the opening ceremony of the 42nd AAGL global congress on minimally invasive gynecology on November 11. His answer to this question (which of course referred to obstetrics and gynecology) was a resounding "yes," and he backed up this conviction with statistics and anecdotes that illustrated the need for specialized training in minimally invasive gynecologic procedures.
Dr. Magrina noted that one effect of the 80-hour-a-week rule is that gynecology residents have 6 fewer months of training than before and that the minimum requirements for gynecologic surgery residents are much lower than for residents in general surgery. "Minimally invasive surgery is the future," he asserted, and "from 'hands-in' to 'instruments-in' takes a longer learning curve."
To drive home his point that specialized training builds skills, Dr. Magrina showed videos of stunt drivers maneuvering cars into impossibly small spaces at high speeds and one of a pilot managing to land a plane that had lost a wing. The point was not lost on the audience-specialized skills require specialized training. Those stunt drivers are probably not also mechanics.
Another issue adding to the need is the change in procedure frequency. "Are there enough patients to sustain/improve/incorporate new MIGS [minimally invasive gynecologic surgery] skills?" Dr. Magrina asked. In 1980 the average ob/gyn performed 28 hysterectomies in a year, he noted; in 2010 this had fallen to 8.5. It is time, he said, to create a MIGS subspecialty.
Dr. Magrina is a professor of obstetrics and gynecology at Mayo Graduate School of Medicine at Mayo Clinic Arizona.
Subscribe to Contemporary Ob/Gyn to get monthly expert advice for today's Ob/Gyn.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Nipocalimab shows promise in preventing hemolytic disease of the fetus and newborn
August 21st 2024The investigational drug could prevent the rare fetal disease HDFN (hemolytic disease of the fetus and newborn) by stopping harmful antibodies from transferring through the placenta during pregnancy.
Read More